IPO

News

Psilocybin is a naturally occurring psychedelic prodrug compound produced by more than 200 species of mushrooms, collectively known as psilocybin mushrooms.

MindMed aims for Nasdaq listing after Compass' magic mushroo...

Compass Pathways and its potential magic mushroom depression drug went public last week – and now psychedelic therapy firm Mind Medicine is aiming to follow suit by up-listing its shares on

News

Compass plans $100m IPO to fund magic mushroom depression dr...

UK biotech Compass Pathways is planning a $100 million US IPO as it seeks to further develop its depression treatment based on psilocybin – an active ingredient that can be found in magic m

News

Inozyme plans $75m IPO as it heads for clinic with rare bone...

US biotech Inozyme Pharma is the latest to jump on to the IPO bandwagon, setting terms for a $75 million stock market launch, as the firm gears up for clinical trials of its lead drug for r

News

Businessmen trading stocks online. Stock brokers looking at graphs, indexes and numbers on multiple computer screens. Colleagues in discussion in traders office. Business success concept.

Poseida Therapeutics aims for $115m stock market launch to f...

California biotech Poseida Therapeutics has become the latest biotech to hit the IPO trial after a string of launches last week, seeking $115 million in funding for projects including a CAR

News

Royalty Pharma shares surge 59% after $2.2 billion IPO

Biopharma initial public offerings are back with a bang after a coronavirus pandemic lull, as Royalty Pharma raised a record-breaking $2.2 billion from the sale of 77 million s

News

Royalty Pharma plans largest IPO of the year so far

Royalty Pharma is planning the biggest IPO of the year as the market’s appetite for biotech stocks remains strong.

MindMed aims for Nasdaq listing after Compass' magic mushroo...

Compass plans $100m IPO to fund magic mushroom depression dr...

Inozyme plans $75m IPO as it heads for clinic with rare bone...

Poseida Therapeutics aims for $115m stock market launch to f...

Royalty Pharma shares surge 59% after $2.2 billion IPO

Royalty Pharma plans largest IPO of the year so far

Protego's $130m for amyloidosis drug, and other financings

How to meet your physicians where they are online

IPO

Editor's Picks